# Study on Comprehensive Quality Control of Herba Hyssopi Based on Chemical Components and Pharmacological Mechanism Action

**Authors:** Zhenxia Zhao, Jiangning Peng, Yingfeng Du, Xinyi Yang, Lilan Fan, Cong Li, Amatjan Ayupbek, Hui Li, Yongli Liu

PMC · DOI: 10.3390/molecules31020205 · 2026-01-06

## TL;DR

This study develops a method to assess the quality of Herba Hyssopi using chemical and pharmacological analysis to detect adulteration and identify key bioactive compounds.

## Contribution

A validated HPLC method for quantifying three bioactive compounds in Herba Hyssopi is introduced for quality control.

## Key findings

- 41 chemical constituents were identified in Herba Hyssopi using UPLC-LTQ-Orbitrap-MS.
- Seven key target genes (e.g., EGFR, MMP9) were linked to the therapeutic effects of Herba Hyssopi via network pharmacology.
- Diosmin, linarin, and rosmarinic acid reduced nitric oxide and pro-inflammatory cytokines in cell experiments.

## Abstract

Herba Hyssopi is a key remedy in Uighur medicine for asthma and cough, frequently used as the monarch or minister herb in prescriptions. However, the lack of effective quality assessment methods complicates the detection of adulteration with common substitutes. In this study, UPLC-LTQ-Orbitrap-MS, network pharmacology, molecular docking, and cell experiments were employed to establish scientific and effective quality control methods to differentiate Hyssopus cuspidatus Boiss from its common adulterants. The results showed that a total of 41 chemical constituents were identified from Herba Hyssopi. Network pharmacology analysis revealed 133 potential target genes associated with its therapeutic actions, among which EGFR, MMP9, TNF, PTGS2, MAPK3, ESR1, and TP53 emerged as key targets. Cellular experiments further demonstrated that diosmin, linarin, and rosmarinic acid significantly suppressed nitric oxide (NO) generation and the release of pro-inflammatory cytokines. Based on these findings, a validated HPLC method was established for the simultaneous quantification of these three bioactive markers, providing a reliable tool for the quality assessment and authentication of Herba Hyssopi. This study offers a scientific basis for improving the standardization and quality control of Herba Hyssopi in traditional medicine applications.

## Linked entities

- **Genes:** EGFR (epidermal growth factor receptor) [NCBI Gene 1956], MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318], TNF (tumor necrosis factor) [NCBI Gene 7124], PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743], MAPK3 (mitogen-activated protein kinase 3) [NCBI Gene 5595], ESR1 (estrogen receptor 1) [NCBI Gene 2099], TP53 (tumor protein p53) [NCBI Gene 7157]
- **Chemicals:** diosmin (PubChem CID 5281613), linarin (PubChem CID 5317025), rosmarinic acid (PubChem CID 639655), nitric oxide (PubChem CID 145068)
- **Diseases:** asthma (MONDO:0004979)

## Full-text entities

- **Genes:** MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, MAPK3 (mitogen-activated protein kinase 3) [NCBI Gene 5595] {aka ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743] {aka COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}
- **Diseases:** asthma (MESH:D001249), cough (MESH:D003371), inflammatory (MESH:D007249)
- **Chemicals:** linarin (MESH:C008282), NO (MESH:D009569), Hyssopi (-), diosmin (MESH:D004145), rosmarinic acid (MESH:C041376)
- **Species:** Dracocephalum cuspidatum (species) [taxon 1439902]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12844281/full.md

---
Source: https://tomesphere.com/paper/PMC12844281